A world without Parkinson’s will only be made possible through the work and energy of the Parkinson’s community – people living with the disease and their loved ones, lawmakers and clinicians, researchers, industry leaders and others. Catalyzing that community is one of The Michael J. Fox Foundation’s (MJFF) four main areas of focus, along with more clearly defining Parkinson’s disease, building better treatment pipelines and speeding clinical trial decision-making.

A world without Parkinson’s will only be made possible through the work and energy of the Parkinson’s community — people living with the disease and their loved ones, researchers, clinicians, industry leaders, lawmakers and others. Catalyzing that community towards productive action is one of The Michael J. Fox Foundation’s (MJFF) four main areas of research focus in its Strategic Research Agenda, along with more clearly defining Parkinson’s disease, building better treatment pipelines and speeding clinical trial decision-making.

In this episode of The Michael J. Fox Foundation Parkinson’s Podcast, part of its award-winning Parkinson’s Science POV series, Maggie Kuhl, vice president of patient engagement at MJFF, leads a conversation about these efforts with two veteran scientists:

1. Brian Fiske, PhD, chief scientist, MJFF
2. Mark Frasier, PhD, chief scientist, MJFF

Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0

There are so many ways to get involved in Parkinson’s community, whether it’s becoming an advocate, joining Team Fox or participating in research. Learn more at michaeljfox.org

The Foundation’s landmark study, the Parkinson’s Progression Markers Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi